Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis

Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis

0 Umsagnir
0
Episode
1037 of 1042
Lengd
29Mín.
Tungumál
enska
Gerð
Flokkur
Viðskiptabækur

Today's guest is Scott Bradley, VP of AI and Innovation at Novartis. As the eighth largest pharmaceutical company in the world by revenue, Novartis' medicines reach millions of people worldwide. Their focus on the discovery and development of novel, breakthrough treatments sees them reimagining not just the delivery of said treatments, but the practice of medicine at large. Scott joins Emerj Editorial Director Matthew DeMello to examine how artificial intelligence is transforming trial design, operations, and patient engagement — while also reshaping industry trust and accountability. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
Prófa frítt
is Device Banner Block 894x1036
Cover for Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis

Other podcasts you might like ...